MedTrace Logo

Omega-3 Fatty Acid and Colorectal Adenoma

NCT06427109 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 798

Last updated 2024-05-24

No results posted yet for this study

Summary

Patients aged \>40 years who underwent elective colonoscopies were recruited from ten institutions. Patients with a history of colorectal cancer or long-term dietary interventions were excluded. Participants completed a food frequency questionnaire (FFQ) prior to endoscopy. FFQ data were analyzed using energy-, age-, sex-, and body mass index-adjusted models; the dietary supplemental omega-3 intake was analyzed separately. Colonoscopy outcome data, including the adenoma number, pathology, and location, were collected. Participants were stratified into omega-3 consumption quartiles to assess colorectal adenoma incidence trends using P for trend analysis.

Conditions

  • Colorectal Neoplasms
  • Adenoma Colon

Interventions

DIETARY_SUPPLEMENT

Dietary intake of omega-3 fatty acid

Participants were stratified into omega-3 consumption quartiles to assess colorectal adenoma incidence trends

Sponsors & Collaborators

  • DongGuk University

    lead OTHER

Principal Investigators

  • Yun Jeong Lim · DongGuk University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-11-30
Completion
2024-02-21

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06427109 on ClinicalTrials.gov